Legend Biotech Corp.

With new long-term survival data at the recently concluded American Society of Clinical Oncology meeting, Johnson & Johnson and Legend Biotech are less and less shy about using the word “cure” in

The 2025 American Society of Clinical Oncology conference will take place in Chicago from 30 May-3 June, and while it typically leans toward solid tumors, it also often features a number of important

Gene therapy-focused bluebird bio and its prospective buyers – private equity firms Carlyle and SK Capital Partners – are offering an additional option for bluebird shareholders to sell their stock, i

As Chinese biotech companies have faced a cash crunch at home, it has become necessary for them to look abroad for partnering opportunities to advance their assets through the clinic. This trend has l